Rosett Max

Rosett Max is listed in filings as Chief Financial Officer at Immunome, Inc.. This profile follows SEC Form 4 activity through Apr 3, 2026, including sale activity. Recent filings connect the profile to Immunome, Inc. (IMNM). The current snapshot covers public activity from Aug 13, 2024 to Apr 3, 2026. Reported amounts are shown as $1.4M to $33.4K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.